Pharmaceutical Preparations · SAN DIEGO, CA, United States
$18.87
+6.91% (+$1.22)2026-04-22
Price Performance
Historical data including institutional events
Loading price data...
Company Profile
D
Daniel Faga
CEO & Executive Director
First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases.
First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026.
First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California.
First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.
Founded
2025
Headquarters
SAN DIEGO, CA, United States
Peer ComparisonRevenue ($B)
▾
Loading comparison...
Recent Insider Trades
Faga Daniel — Purchase (Derivative) 69,355 shares at $0.00 on 2026-04-20
FENTON DENNIS M — Purchase (Derivative) 4,000 shares at $0.00 on 2026-04-20
Orwin John A — Purchase (Derivative) 1,300 shares at $0.00 on 2026-04-20
Lizzul Paul F. — Purchase (Derivative) 45,000 shares at $0.00 on 2026-04-20
Lizzul Paul F. — Purchase (Derivative) 25,575 shares at $0.00 on 2026-04-20